Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1176
SPS Commerce
SPSC
$2.96B
| $23.1M | 0.01% |
259,426
+88,162
| +51% | +$8.17M |
2013 Q2
50 quarters
|
|
1177
Fluor
FLR
$6.67B
| $23.1M | 0.01% |
583,444
+138,369
| +31% | +$6.12M |
2013 Q2
50 quarters
|
|
1178
JB Hunt Transport Services
JBHT
$22B
| $23.1M | 0.01% |
118,757
-322,111
| -73% | -$55.3M |
2013 Q2
50 quarters
|
|
1179
SPX Corp
SPXC
$8.67B
| $23.1M | 0.01% |
115,297
+34,906
| +43% | +$7.12M |
2013 Q2
50 quarters
|
|
1180
CALL
Berkshire Hathaway Class B
BRK.B
$1.08T
| $23M | 0.01% |
45,700
+700
| +2% | +$348K |
2024 Q4
4 quarters
|
|
1181
PUT
Chevron
CVX
$405B
| $22.9M | 0.01% |
150,000
-53,100
| -26% | -$8.09M |
2024 Q3
5 quarters
|
|
|
BLD
1182
DELISTED
TopBuild
BLD
| $22.9M | 0.01% |
54,786
+7,632
| +16% | +$3.27M |
2015 Q3
41 quarters
|
|
1183
Zoom
ZM
$27.1B
| $22.8M | 0.01% |
264,261
-5,162
| -2% | -$434K |
2019 Q2
26 quarters
|
|
1184
CALL
TKO Group
TKO
$12.8B
| $22.8M | 0.01% |
109,000
-16,000
| -13% | -$3.11M |
2025 Q2
2 quarters
|
|
|
GRFS
1185
Grifois
GRFS
$4.98B
| $22.8M | 0.01% |
2,434,636
+1,387,783
| +133% | +$12.6M |
2018 Q1
31 quarters
|
|
1186
Warner Music
WMG
$14B
| $22.7M | 0.01% |
741,487
-1,119,200
| -60% | -$34.2M |
2023 Q2
10 quarters
|
|
1187
Applied Industrial Technologies
AIT
$12.6B
| $22.7M | 0.01% |
88,547
-11,697
| -12% | -$2.99M |
2016 Q1
39 quarters
|
|
1188
PUT
Procter & Gamble
PG
$337B
| $22.7M | 0.01% |
158,400
| – | – |
2024 Q3
5 quarters
|
|
1189
PUT
RTX Corp
RTX
$249B
| $22.7M | 0.01% |
123,600
-12,700
| -9% | -$2.21M |
2024 Q3
5 quarters
|
|
|
NBIS
1190
PUT
Nebius Group N.V.
NBIS
$66B
| $22.6M | 0.01% |
270,500
-4,500
| -2% | -$466K |
2025 Q1
3 quarters
|
|
1191
State Street Industrial Select Sector SPDR ETF
XLI
$30.5B
| $22.6M | 0.01% |
145,902
+99,899
| +217% | +$15.4M |
2013 Q2
50 quarters
|
|
|
1192
PUT
Berkshire Hathaway Class B
BRK.B
$1.08T
| $22.6M | 0.01% |
45,000
| – | – |
2025 Q1
3 quarters
|
|
1193
XPO
XPO
$21.8B
| $22.6M | 0.01% |
166,120
+5,741
| +4% | +$782K |
2013 Q2
50 quarters
|
|
1194
PUT
AbbVie
ABBV
$464B
| $22.6M | 0.01% |
98,800
| – | – |
2024 Q3
5 quarters
|
|
1195
Madrigal Pharmaceuticals
MDGL
$11.5B
| $22.5M | 0.01% |
38,720
-11,192
| -22% | -$5.72M |
2013 Q2
50 quarters
|
|
1196
PUT
Antero Resources
AR
$10.5B
| $22.4M | 0.01% |
650,000
-881,500
| -58% | -$29.9M |
2025 Q3
1 quarter
|
|
1197
CALL
Applied Materials
AMAT
$429B
| $22.4M | 0.01% |
87,000
-84,900
| -49% | -$20.4M |
2023 Q4
8 quarters
|
|
1198
Urban Outfitters
URBN
$6.92B
| $22.4M | 0.01% |
297,030
+61,298
| +26% | +$4.34M |
2013 Q2
50 quarters
|
|
1199
Hexcel
HXL
$6.53B
| $22.3M | 0.01% |
302,418
-44,738
| -13% | -$3.16M |
2013 Q2
50 quarters
|
|
1200
Maximus
MMS
$2.76B
| $22.3M | 0.01% |
258,604
+34,058
| +15% | +$2.91M |
2013 Q2
50 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.